Reviewing The Case For Gevo Inc (GEVO) Going Higher

Currently, there are 240.50M common shares owned by the public and among those 230.97M shares have been available to trade.

The company’s stock has a 5-day price change of 17.50% and -39.23% over the past three months. GEVO shares are trading -37.13% year to date (YTD), with the 12-month market performance down to -53.25% lower. It has a 12-month low price of $0.60 and touched a high of $1.86 over the same period. GEVO has an average intraday trading volume of 6.82 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.76%, -12.03%, and -38.41% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of Gevo Inc (NASDAQ: GEVO) shares accounts for 37.09% of the company’s 240.50M shares outstanding.

It has a market capitalization of $175.40M and a beta (3y monthly) value of 2.86. The earnings-per-share (ttm) stands at -$0.28. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.04% over the week and 8.37% over the month.

Analysts forecast that Gevo Inc (GEVO) will achieve an EPS of -$0.07 for the current quarter, -$0.07 for the next quarter and -$0.51 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.07 while analysts give the company a high EPS estimate of -$0.07. Comparatively, EPS for the current quarter was -$0.07 a year ago. Earnings per share for the fiscal year are expected to decrease by -10.53%, and -23.88% over the next financial year. EPS should shrink at an annualized rate of 25.00% over the next five years, compared to 45.44% over the past 5-year period.

Looking at the support for the GEVO, a number of firms have released research notes about the stock. Northland Capital stated their Market Perform rating for the stock in a research note on August 21, 2023, with the firm’s price target at $2. UBS coverage for the Gevo Inc (GEVO) stock in a research note released on December 14, 2022 offered a Neutral rating with a price target of $2.25. Jefferies was of a view on October 19, 2022 that the stock is Hold, while Citigroup gave the stock Buy rating on February 09, 2022, issuing a price target of $5. Stifel on their part issued Buy rating on August 24, 2021.

Most Popular

Related Posts